NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 245 filers reported holding NEKTAR THERAPEUTICS in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,171,000 | +3398.0% | 530,800 | +4556.1% | 0.17% | +2716.7% |
| Q3 2021 | $205,000 | +10.8% | 11,400 | +4.7% | 0.01% | -14.3% |
| Q4 2020 | $185,000 | -76.5% | 10,892 | -70.2% | 0.01% | -89.9% |
| Q4 2019 | $788,000 | +203.1% | 36,528 | +156.1% | 0.07% | +187.5% |
| Q3 2019 | $260,000 | -38.8% | 14,264 | +19.4% | 0.02% | -38.5% |
| Q2 2019 | $425,000 | -49.0% | 11,944 | -72.0% | 0.04% | -77.5% |
| Q2 2017 | $833,000 | – | 42,600 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |